-
According to the Las Vegas Review-Journal, the trial for two women who have filed a lawsuit against Takeda Pharmaceuticals over the drug Actos was expected to begin last week. The Review-Journal reported that Delores Cipriano, 81, of Henderson
-
Due to concerns over diabetes drug Actos’ links to bladder cancer, the US Food and Drug Administration (FDA) is currently performing a five-year study on Actos. For more information about the FDA study and Actos, click
-
According to the Atlanta Business Chronicle, the family of a nine-year-old girl has filed a lawsuit in the U.S. District Court for the Middle District of Georgia that alleges a pharmacy filled a prescription incorrectly, causing
-
We have reported several times over the last couple of months about the dangers of acetaminophen (Tylenol), which sends thousands of people to emergency rooms each year with injuries. Each year, some 80,000 people are treated
-
Updating a story we brought you earlier this year: unfortunately, a federal judge in Louisiana has reduced the amount of damages awarded in an Actos product liability case from more than $9 billion to $38.1
-
Drug manufacturer GlaxoSmithKline reached a $45 million settlement last month with the state of Louisiana over allegations that the company broke several laws while marketing its drugs. According to the New Orleans Times-Picayune, Louisiana Attorney General
-
According to Bloomberg News, Takeda Pharmaceutical Co. is alleged to have duped patients and doctors about the risks of the diabetes drug Actos, leaving it potentially liable for the cancer death of a former U.S. Army translator.
-
As reported by the New York Times (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number of severe adverse events such as renal failure, increases in blood sugar, abdominal issues and even death from the highly-promoted and costly
-
Depacon, Depakote, Depakote CP, Depakote ER, Depakene and Stavzor have been linked to cognitive problems (such as decreased IQ scores, autism and Asperger’s syndrome) and physical birth defects (such as spina bifida, atrial septal defect, cleft
-
According to the Cleveland Plain Dealer, Abrams Royal Compounding Pharmacy, a Dallas-based pharmaceutical product supplier, is recalling all of its unexpired sterile products after an adverse patient event. The US Food and Drug Administration (FDA) announced
